Calabasas, CA (PRWEB) October 24, 2013
The Bio Supply Management Alliance (BSMA) has named five eminent leaders from the biotech industry to serve on the Board of Advisors to direct the mission of advancing a holistic end-to-end supply chain perspective for biotech.
Devendra Mishra, Executive Director of BSMA, observed, “BSMA, the only one of its kind organizations of supply chain professionals in the world, is privileged to have Paul Anderson, Paul Seaback, Mary Kachinsky, Richard Dawe and Susanne Somerville to expand and deepen the leadership of its Advisory Board. It augurs extremely well as these eminent leaders of our industry bring their unique insights, knowledge and experience to take the Alliance to the next frontier of service.”
The Advisory Board drives the mission of the Alliance to 1. Build effective and efficient biotech supply chain management strategies by developing, advancing, and disseminating best practices, knowledge, and research, 2. Invent innovative approaches for the highest quality and clinical outcomes in patient care, and 3. Create a community of supply chain management thought and practice leaders from the business, professional, and academia.
Paul Anderson, the Vice President of Strategic Operations at Life Technologies Corporation, has responsibility for leading major programs that enhance the global operations infrastructure of the company. Mr. Anderson previously led the global procurement organization at Life Technologies. He was formerly a senior executive leader at Applied Biosystems and led the global procurement, sales & operations planning, global distribution, program management and business systems organizations. Mr. Anderson also held leadership positions in supply chain and manufacturing at Perkin-Elmer Corporation and General Electric. Mr. Anderson is a graduate of the GE Manufacturing Management Program and has a Bachelor of Science, Magna Cum Laude, in Industrial Engineering, from Oregon State University and an MBA from Harvard Business School. He serves on the board of directors of BIOCOM Purchasing Group.
Paul Seaback is the Head of Global Supply Chain at Gilead Sciences. He has an extensive background in the pharmaceutical industry, including active pharmaceutical ingredient (API), drug product (DP) and medical device encompassing domestic and international supply chains. Prior to joining Gilead, from September 2008 till March 2013, Seaback was the Vice President of Manufacturing and Global Supply Chain at Medicis Pharmaceutical Corporation. He has also held leadership roles with Hospira, Mayne Pharma, NaPro Bio, Cardinal Health and Novartis. During his career he has implemented leading initiatives. His notable accomplishments include; a global Supplier Relationship Management program, a Risk Management program to identify and mitigate supply and supplier risks, and Supply & Demand and S&OP processes. His approach uses quantitative methodologies and collaboratively designed processes that influence behavior and drive performance amongst organizations to achieve targets across the global supply chain. Seaback holds a Bachelor of Science degree in Business, Economics and Marketing from Colorado State University.